Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shih-Jen Liu

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
International Journal of Biological Sciences|June 16, 2023
TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responsesJing-Xing Yang, Jen-Chih Tseng, Chih-Feng Tien, et al.
Vaccine|January 20, 2009
A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine designHsin-Wei Chen, Shih-Jen Liu, Hsueh-Hung Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 23, 2023
A flexible liposomal polymer complex as a platform of specific and regulable immune regulation for individual cancer immunotherapyChia-Hung Chen, Tzu-Han Weng, Hsiao-Hsuan Huang, et al.
Nature Cancer|January 24, 2024
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapyYu-Kai Huang, Wei-Chung Cheng, Ting-Ting Kuo, et al.
Frontiers in Immunology|May 19, 2022
Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal InfectionJhe-Jhih Lin, Chih-Feng Tien, Yi-Ping Kuo, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
International Journal of Biological Sciences|June 16, 2023
TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responsesJing-Xing Yang, Jen-Chih Tseng, Chih-Feng Tien, et al.
Vaccine|January 20, 2009
A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine designHsin-Wei Chen, Shih-Jen Liu, Hsueh-Hung Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 23, 2023
A flexible liposomal polymer complex as a platform of specific and regulable immune regulation for individual cancer immunotherapyChia-Hung Chen, Tzu-Han Weng, Hsiao-Hsuan Huang, et al.
Nature Cancer|January 24, 2024
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapyYu-Kai Huang, Wei-Chung Cheng, Ting-Ting Kuo, et al.
Frontiers in Immunology|May 19, 2022
Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal InfectionJhe-Jhih Lin, Chih-Feng Tien, Yi-Ping Kuo, et al.
Pageof 12